Exploring the Roots of Cancer to Improve Outcomes
Laboratory scientists at Hackensack University Medical Center are collaborating with clinicians at John Theurer Cancer Center and with investigators at Georgetown Lombardi Comprehensive Cancer Center and other institutions to explore hematopoietic stem cell biology and optimize transplantation, study genetic and epigenetic variants influencing cancer risk, and delineate biomarkers that predict cancer progression, among other topics. The findings of their investigations hold promise for gleaning new insights into the roots of cancer development and determinants of outcomes in people being treated for cancer.
You may also be interested in
Translational research by definition brings knowledge from bench to bedside to offer as early as possible advanced options in difficult to treat cancers. This includes a strong dedication from John Theurer Cancer Center to customize treatment through precision medicine.
The Genetics Service, a leader in clinical genetics in the metropolitan area for over 30 years, offers genetic services and testing for both children and adults. The goal is to provide patients with the important information they need through risk assessment evaluations, testing, management, and supportive counseling.
Our patients have access to tomorrow’s cancer medicines including new agents which can offer successful alternatives to chemotherapy. The depth and breadth of experience of our world class experts, who each focus on specific subtypes of cancer, results in the best available personalized care.